# OnCo record thomas-helleday (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/thomas-helleday/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "thomas-helleday" ;
  schema:name "Thomas Helleday"@en ;
  schema:description "Co-discovered that PARP inhibitors kill BRCA-deficient cells, the synthetic lethality behind olaparib and its successors."@en ;
  schema:url <https://onco.cc/people/thomas-helleday/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Helleday%20T%5BAuthor%5D%20PARP%20synthetic%20lethality> ;
  onco:tag "parp", "synthetic-lethality", "discovery" ;
  schema:jobTitle "Professor of Chemical Biology, Karolinska Institutet; Professor, University of Sheffield" ;
  schema:sameAs <https://orcid.org/0000-0002-7384-092X> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/synthetic-lethality-approaches/> ;
  onco:targets <https://onco.cc/targets/parp/>, <https://onco.cc/targets/brca/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/> ;
  onco:institutions <https://onco.cc/institutions/karolinska/> ;
  onco:journals <https://onco.cc/journals/molecular-oncology/> ;
  schema:affiliation <https://onco.cc/institutions/karolinska/> .
